Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/28/26 19:50 | 1/26/26 | ABOS | Health | BioPrd | Biological Products, (No Diag | Meisner Derek M | MA | O | GC,Corp | 4 | S.dm | -214 | 2.06 | 0 | -104 | 174 | D | |||||||||||||||
1/23/26 18:12 | 1/21/26 | ABOS | Health | BioPrd | Biological Products, (No Diag | Siemers Eric | MA | O | Chief Me | 2 | S.m | -27 | 1.93 | 0 | -14 | 255 | D | |||||||||||||||
1/23/26 18:11 | 1/21/26 | ABOS | Health | BioPrd | Biological Products, (No Diag | Zuga Matt | MA | O | CFO,Chie | 3 | S.m | -50 | 1.91 | 0 | -26 | 305 | D | |||||||||||||||
1/23/26 18:10 | 1/21/26 | ABOS | Health | BioPrd | Biological Products, (No Diag | Oconnell Daniel Joseph | MA | DO | CEO | 3 | S.m | -163 | 1.90 | 0 | -86 | 881 | D | |||||||||||||||
1/23/26 18:10 | 1/21/26 | ABOS | Health | BioPrd | Biological Products, (No Diag | Barton Russell | MA | O | COO | 3 | S.m | -30 | 1.91 | 0 | -16 | 205 | D | |||||||||||||||
1/9/26 16:39 | 1/7/26 | ABOS | Health | BioPrd | Biological Products, (No Diag | Doherty James J. | MA | O | P,CDO | 1 | S.m | -15 | 1.85 | 0 | -8 | 54 | D | |||||||||||||||
1/9/26 16:38 | 1/7/26 | ABOS | Health | BioPrd | Biological Products, (No Diag | Schacterle Amy | MA | O | Chief Re | 1 | S | -2 | 1.98 | 0 | -1 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |